bluuebunny/crossref_metadata_2025_split huggingface dataset:
2368 – Intravenous Drug Users- Screening & Vaccination Programme
Authors: Sharma J. , Manarkattu M. , Ravi P. , Naughton C. 
Published: July 2013

IntroductionPrevalence and incidence rates of both Hepatitis B and C is on the rise in United Kingdom, and worldwide. Intravenous drug users (IVDU) are particularly at risk due to their chaotic lifestyle. Testing enables early treatment, and vaccination is an effective method of prevention.ObjectivesAssess awareness of screening and vaccination programmes (VP) amongst IVDUs, and willingness to engage in these if they were available and accessible.AimsOur sample population was IVDUs presenting to a Community Substance Misuse team, in central England and the criteria we assessed were: whether they admitted to needle-sharing, awareness of screening and VPs, previous screening and vaccination history, and willingness to engage in VPs.MethodsData was collected through a performa with related questions, after identifying and communicating to key workers; and presented in graphs. We looked at the first 100 responses.ResultsMore than a third of IVDU in the population shared needles, one-third had not even been tested for Hep B/C, a half had been immunised. Most of them are aware of the risks, and would agree to the immunisation programme if available, at Lantern House.ConclusionsPrevalence of IVDU presenting to a Substance Misuse clinic is quite high. Screening and vaccination against Hepatitis of IVDU is lacking, despite it being feasible, necessary and acceptable by patients. Screening for the disease will aid diagnosis and hence early treatment, and will create a gateway for prevention by using VPs.
2377 – Introduction Of a Baby-mother -(father) Unit Into The Hungarian Health Service System. Results After Five Years
Authors: Kurimay T. , Németh T. , Hedervari-Heller E. , Babus E. , Madarasi A. , Tary V. , Atkári G. , Kovács Z. , Seres G. , Fenyves T. , Simon Z. , Hegedűs E. , Pelikán A. , Táncsics D. , Tunyi T. , Zalatnai Z. , Hámori E. 
Published: July 2013

The Baby-Mother-(Father) program started in 2007, after a preparatory phase in a collaboration with the Zentrum Für Soziale Psychiatrie - Mutter & Kind Behandlung, Heppenheim, Germany. In Hungary, this is the first dedicated program for a babymother unit, were initiated by National Institute of Child Health (OGYEI), and Saint John Hospital Psychiatric and Psychiatric Rehabilitation Department in Budapest.ObjectiveBaby-mother unit introduction into the local and the Hungarian health service.The aim of the program is to apply a collaborative therapeutic and rehabilitation model utilizing the multidisciplinary team work in the treatment of the pre-, peri- and post-natal period of mothers suffering mental disorders as well as to facilitate the early interactions and attachment with the baby.Since 2007, 82 mothers, 1 father entered into the program. 54 mothers were participated as inpatient, 29 were treated only as outpatient. 24.9% of the cases were diagnosed (ICD 10 – F20–F29) schizophrenia or spectrum disorders, 27,6% were in the major affective disorders, including bipolar, (F 31, 14.5%). 38,6% were diagnosed in the anxiety disorders spectrum. 23% entered in the prenatal period (pregnancy), while 76,3% entered post-natal.Therapeutic methods usedCase-management, individual, group and family interventions (psychotherapy), pharmacotherapy, case conferences, individual and staff supervision, video-feedback, mother-child consultation.ResultsNew treatment model introduction in Hungary, which may reduce the risk of the separation of the baby, enhances the mother recovery, as well as the utilization of the family's and the supportive network resources. Further research is needed to prove the higher efficacy.
2474 – Presentation on Con
Authors: Gaebel W. 
Published: July 2013

Introduction:ICD-11 and DSM-5 differ in the role of functional impairments for the diagnosis of a mental disorder in general. While a DSM-5 diagnosis of a mental disorder includes functional impairment as a mandatory component, ICD-11 does not.Objectives:To clarify the reasoning behind the decision of WHO not to include functional impairment as a mandatory diagnostic criterion.Aims:To present arguments for not including functional impairment in the diagnostic criteria for mental disorders.Methods:Presentation of con arguments.Results:WHO prefers functional criteria not to be included among the clinical criteria (Reed et al., 2011) and suggests using the International Classification of Functioning (ICF) to assess and code such functional impairments. Functional impairments are not always present in persons with schizophrenia, they are not disorder-specific and a WHO study has shown that their occurrence in persons with psychosis-like experiences in the general population does not inevitably indicate schizophrenia or other mental disorders (Nuevo et al., 2010).Conclusions:DSM-5 will retain the mandatory criterion of functional impairment, while ICD-11 will not include it. The question of caseness with and without mandatory functional impairments in the diagnostic criteria will be one of the research issues for the upcoming ICD-11 field trials.
2475 – European Guidance - A Project of the European Psychiatric Association
Authors: Gaebel W. 
Published: July 2013

Introduction:The European Psychiatric Association (EPA) created the European guidance project which will provide a series of guidance documents on topics related to the quality of mental healthcare service structures and the prevention of mental disorders, for which evidence- and consensus-based guidelines are currently lacking.Objectives:To provide information on good clinical practice, using problem solving examples, guidelines and quality standards of care for European providers of mental healthcare, national societies and health authorities, to address health care gaps, and to give advice on developing research programs.Aims:The aim of the “EPA Guidance on the quality of mental health services” is the provision of recommendations for optimal structures of mental healthcare services by identifying and evaluating the current evidence and comparing the efficacy of different service structures wherever possible.Methods:Recommendations, which were divided into structure recommendations and process recommendations, were developed on the basis of systematic literature researches and a peer review process within the EPA. Recommendations were supplemented by quality indicators and their evidence base was graded by a three-part evidence rating system.Results:In total, 30 evidence- and consensus-based recommendations were developed, which comprise ten general and six service-type-specific structure recommendations, and four general and ten specific process recommendations.Conclusion:The initial panel of recommendations on European mental healthcare service structures needs to be tested in each European country with the aim to further develop the recommendations based on the feedback from users.
2514 – Eu Proposed Strategies to Diminish the Burden of Mental Disorders
Authors: Hübel M. 
Published: July 2013

Mental disorders are a leading cause of chronic disease and disability in the EU.Supporting Member States in addressing depression and suicide (including under use of eHealth), replacing institutional by community-based,socially-inclusive treatment and care models (including through the use of EU-Structural Funds), strengthening promotion and prevention as core mission of mental health systems are key objectives of EU-mental health policy. Increasing the mental health literacy of citizens and empowering patients are further priorities.Psychiatry plays a key role: where necessary, it needs to strengthen patient-centred treatment models and their practice in the community, engage more in multisectorial cooperation for early interventions, promote social inclusion of people with mental health problems, support other sectors (workplaces, schools, local communities), strengthen ties with other medical disciplines to improve their training on mental health and better treatment of co-morbidity of physical and mental disorders.In 2008, the European Commission launched the European Pact for Mental Health and Well-being. Ministers of Health adopted Council Conclusions in 2011. A Joint Action on Mental Health and Well-being co-financed from the EU-Health Programme was launched early 2013, involving more than 20 Member States. The Joint Action will review the scientific evidence and country situations, deliver country-specific policy recommendations and develop a common framework for action on mental health and well-being.Mental health is embedded in the context of EU-health policy on chronic disease.Good practices in policy and stakeholder action are collected and disseminated through the database EU Compass for Action on Mental Health and Well-being (http://ec.europa.eu/health/mental_health/eu_compass/index_en.htm).
2518 – Internet-Based Treatment for Mental Disorders
Authors: Lindefors N. 
Published: July 2013

Internet-based cognitive behaviour therapy (ICBT) is a new and promising treatment for psychiatric and other medical disorders. The aim of this presentation is to determine the applications, clinical efficacy and cost-effectiveness of ICBT.Results from several studies using RCT protocols provide consistent evidence to support clinical efficacy with large effect size of ICBT for depression, panic disorder and social phobia. in addition, preliminary evidence for large effect size is seen for several other disorders such as e.g. severe health anxiety, irritable bowel disorder, eating disorders, cannabis use and pathological gambling. Moderate or small effects are indicated for some other conditions.Cost-effectiveness analyses suggest that ICBT is cost-effective compared to no treatment or to conventional CBT, respectively. in addition, each therapist can treat at least four to five times more individuals with ICBT as compared to conventional CBT. This is critical since the number of qualified CBT therapists is small compared to the treatment needs.It is concluded that ICBT currently is a well-established and highly cost effective treatment for depression, panic disorder and social phobia. Moreover, in general ICBT is as effective as conventional CBT for respective disorders, i.e. if conventional CBT works then ICBT works.
2521 – Clinical Challenges in Switching Antipsychotics
Authors: Naber D. 
Published: July 2013

Whenever antipsychotic medication is not effective, the first intervention should be to check adherence. If the intake of the oral medication is “relatively” sure and no relevant side effect occurs, the dosage should be increased, if necessary to the maximal tolerated dosage. If side effects do not allow any further increase of the dosage and the antipsychotic drug is taken without any relevant improvement, switching to another antipsychotic is an option most often used. Several issues should be considered:Change only one drug at a time, switch to an antipsychotic with a different pharmacological profile, ask the patient for his/her collaboration, document psychopathology and tolerability before switching and plan to do again two to four weeks after switching to assess success of switching. The switching strategy has been investigated in several studies and no major difference has been found. However, cross tapering for a period of three to seven days is most often used and probably the safest procedure. The efficacy of switching the antipsychotic, although often used in daily practice, has not well been investigated yet. The few clinical studies will be presented. Data can be summarized: to switch from the first atypical antipsychotic to the second, is effective in 20 to 30%, the switching to a third atypical antipsychotic (if not clozapine) is very seldom successful. After two unsuccessful attempts a switch to clozapine should be thoroughly considered.
2526 – Cultural Understanding of Stigma: A Qualitative Study in Families of Patients with Severe Psychiatric Disorders in Iran
Authors: Karamlou S. , Mottaghipour Y. 
Published: July 2013

Introduction:The Stigmatization of psychiatric patients has been observed across the world, and the family members who care for them are the first-hand witnesses of any discriminatory attitudes. Little is known about how the problem manifests differently across cultures.Aims:Study the cultural differences of the experience of stigma in families of patients in Iran.Methods:The qualitative data obtained was based on the responses of 20 families to 10 open-ended questions about stigma. The effect of stigma was rated by two coders with high inter-rater reliability. The rating ranged from “no effect” to “severe effect” of stigma.Results:In 40% of the interviews, family members reported that stigma had had a moderate effect on their lives. The content analysis of the data developed some various categories that showed the caregivers’ perceptions of stigma. Main categories included: concealment (unsupported network, blame for causing the illness, embarrassment); limitations (work, education, relation with other); genetic attribution (tainted other family members via genetic connection with patients); traditional beliefs in society about patient (patients seen as weak and unworthy people); God's wish, burden (burden because of covering and burden of caring) and the importance of gender differences in the stigma of the illness.Conclusions:Patients with psychiatric disorder and their families suffer from stigma with a broad range of negative attributes which may interfere with various aspects of their lives. Concealment and limitations are common experiences in families. Gender differences and God's wish conception are specifically related to cultural factors.
2537 – Talking About Suicide in the Mass Media: From Harmful to Protective Effects
Authors: Niederkrotenthaler T. 
Published: July 2013

Background:Media reporting of suicide has repeatedly been shown to trigger suicidal behavior, with evidence being most consistent for reports on celebrity suicide. Very little is currently known about preventive ways of reporting on suicidality that allow for destigmatization of suicide without harm for those at highest risk.Objectives and aims:This presentation will review what we currently know about the relationship of suicide and media reporting and underlying mechanisms. Public health interventions currently used to prevent copycat behavior will be reviewed, including interventions that restrict media reporting on suicide, and interventions that focus on changing the quality of reporting. Recent findings on a possible preventive effect of media reports on constructive coping in adverse circumstances will be presented and discussed with regard to implications for suicide prevention, in particular for suicide awareness campaigns and the prevention of copycat behavior.Methods:The presentation will include a selective literature review of research on the relationship of media and suicide, intervention studies to prevent imitation effects, and studies at the interface with suicide awareness campaigns. Particularly experiences gained in the translation of the Austrian Suicide Prevention Plan will be presented and contextualized with international developments in the topic area.
2555 – Violence in the Mental Patients: Risk Factors and Comorbidities
Authors: Arfaoui S. , Meziou O. , Charfi N. , Zalila H. 
Published: July 2013

Introduction:Several studies suggest that people with serious mental illness represent a higher risk of violent acting out than the general population.Objective:To evaluate the prevalence of violent behavior in psychiatric patients and compare the group of patients who committed violent acts with nonviolent patients to identify risk factors for violence.Methodology:A retrospective-comparative study was conducted among 160 patients hospitalized in the psychiatric service D of the hospital Razi during the period between 1 July 2011 and 15 October 2011.Results:Among the patients in our sample 78.75% (N = 126) had submitted an act of violence during the month before hospitalization. The male gender was correlated with violence (OR = 2.7). History of violence and criminal history had significant correlations with violence with OR = 2.5. Schizophrenia diagnosis was the most represented among the mentally ill violent. Monitoring irregular and poor adherence to treatment were important risk factors with OR = 2.6. Addictive behavior was found among 49.2% of violent patients. Substance use was correlated with violence (OR = 4.5).Conclusion:It is interesting to note that in recent years the interest of clinicians to the question of violence among the mentally ill has increased. There is also an evolution of psychiatric practice with dimensions of legal framework more rigorous. Clinicians and forensics must continue to work together in this area.
2560 – Esitalopram for Antipsychotic Non-Responsive Complex Visual Hallucinations: Eight Patients Suffering from Charles-bonnet Syndrome
Authors: Berman Y. , Barak Y. 
Published: July 2013

Background:The Charles Bonnet syndrome (CBS) is characterized by distinct visual hallucinations and visual impairment in patients with insight and the absence of psychiatric comorbidity. The number of reported cases of CBS is expanding as the population ages and the prevalence of vision disorders increases. The efficacy of antipsychotics in CBS is based on sketchy evidence. The use of serotonin selective re-uptake antidepressants (SSRI) for CBS is anecdotal.Aim:To describe effectiveness of escitalopram in a series of patients suffering from CBS who were unresponsive to antipsychotic treatment.Methods:Eight consecutive patients suffering from CBS who did not respond to standard antipsychotic treatment were switched to escitalopram. CBS severity prior to escitalopram treatment was quantified using the Clinical Global Impression (CGI) scale and again after 8 weeks of treatment. All had undergone brain -CT and cognitive assessment.Results:There were 4 men and 4 women, mean age 81.7 ± 7.3 years. Brain-CT imaging was normal except for an incidental finding of a small frontal meningioma in one patient. All had MMSE scores ≥ 27/30. Previous antipsychotic treatment was mostly with risperidone 1.0 to 3.0 mgs/daily. Mean CGI-severity upon switching to escitalopram treatment was 5.7. This was significantly reduced to 1.8 (p < 0.001) after 8 weeks of escitalopram treatment (mean dose: 11.8 mgs/daily). There were no side-effects nor adverse events reported.Conclusions:This is the first case-series to show that SSRIs are an effective and well-tolerated treatment for visual hallucinations associated with vision impairment such as in the CBS.
2568 – Effects of a Single 10 Mg Dose of Methylphenidate on Attention Components and Executive Functions in Adults with ADHD
Authors: Ertlé S. , Vanoli L. , Erb A. , Duval F. 
Published: July 2013

Introduction:Attention deficit / hyperactivity disorder (ADHD) affects about 60% of adults who suffered from ADHD in childhood. Methylphenidate is a common off-label treatment.Objectives:The aim of this pilot study was to assess the neuropsychological effects of a single dose of methylphenidate (10 mg orally) on different attention components and executive functions by using the computerized attention assessment battery TAP 2.2 (Testbatterie zur Aufmerksamkeitsprüfung).Methods:Fifteen DSM IV-ADHD adult patients were enrolled into this study. Neuropsychological evaluations were performed at baseline and after the methylphenidate test. Patients were subsequently treated with adequate dose of methylphenidate and followed over a period of 6 months.Results:Compared with baseline, a single dose of methylphenidate induced a significant improvement in working memory (p = 0.001), sustained attention (p = 0.0007) and visual scanning (p = 0.0007) in terms of omissions and mistakes. Reaction times also decreased in tonic arousal (p = 0.002), incompatibility (p = 0.008) and flexibility tasks (p < 0.00001). There was a significant correlation between working memory and sustained attention before and after methylphenidate (both p < 0.01). Among our patients, 12 who responded positively to the methylphenidate test, showed favorable long-term outcome with methylphenidate treatment.Conclusions:Adults with ADHD showed neurocognitive improvements after a single 10 mg dose of methylphenidate. Our results suggest that the methylphenidate test would be useful in predicting subsequent response to methylphenidate treatment in ADHD adult patients. Controlled prospective studies are needed to confirm this hypothesis.
2573 – Bioacoustic Correction in the System of Rehabilitation of the Neurotic and Stress Connected Disorders
Authors: Panchenko L.V. , Panchenko O.A. , Chumak T.E. 
Published: July 2013

By the methodology of bioacoustic correction (the BAC), on the basis of computer transformation, the representation of the parameters of bioelectrical activity of human brain has been transformed into the parameters of sound stimuli.The objective of this research is to study the efficiency and the safety of the BAC method application in the system of rehabilitation neurotic and stress connected disorders. The sample has been given by patients with neurotic, stress connected and somatoform disorders (F40–F48 – 50 persons). The research has been implemented by the device “Sinhro-S” (St.-Petersburg, the Russian Federation).Prior to the beginning and upon termination of the correction, the assessment of psycho emotional condition of patients has been implemented by the means of methodology of subjective interrogation, psychological and psychophysiological testing. Therapy has included pharmacotherapy (antidepressant seretonin selective reuptake inhibitors, adaptogens, neurometabolic, nootrops); psychotherapy (rational, group, corporally-focused, hypnosuggestive, autogenic training); physiotherapy; the BAC. Subjective feelings of influence efficiency have been confirmed by the results of electrophysiological examination. During the therapy all the patients have had perception improvement of a sound image by the means of spectral characteristics reorganization of electroencephalogram and hereupon the new functional condition of the central nervous system has been created. Authentic improvement of quality life indicators have been observed too (vitality, quality of a dream, emotional reactions, physical activity).Thereby, the bioacoustic correction method is modern, effective, safe, not medicamentous means of psychological infringements correction.